Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Danish drugmaker Novo Nordisk said several hundred counterfeit units of its diabetes drug Ozempic were being distributed in the United States.

The FDA has recently approved two new prophylactic treatments for people with hemophilia who develop antibodies to clotting ...

Bagsværd, Denmark-based Novo Nordisk is a global healthcare company ... The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.

Participants included 213 males aged ≥ 12 years with severe hemophilia A or B ... Hema Biologics/LFB SA, Novo Nordisk, Octapharma AG, Pfizer, Sanofi, Spark Therapeutics, and Takeda; as well ...

Hemophilia is a rare genetic condition that keeps your blood from clotting, leading to bleeding problems. Bleeding can happen at any time (spontaneous) or as a result of trauma (injury, cut, or ...